UnitedHealth Group (NYSE:UNH) Issues FY 2026 Earnings Guidance

UnitedHealth Group (NYSE:UNH) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided EPS guidance of 18.250- for the period, compared to the consensus EPS estimate of 17.780. The company issued revenue guidance of -, compared to the consensus revenue estimate of $440.7 billion.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $346.26 on Wednesday. UnitedHealth Group has a twelve month low of $234.60 and a twelve month high of $438.85. The stock has a market capitalization of $314.29 billion, a P/E ratio of 26.25, a PEG ratio of 1.49 and a beta of 0.40. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.72. The business’s fifty day moving average price is $289.27 and its 200 day moving average price is $316.84.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, beating analysts’ consensus estimates of $6.76 by $0.47. The firm had revenue of $111.65 billion for the quarter, compared to analysts’ expectations of $109.84 billion. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The firm’s revenue for the quarter was up 2.0% compared to the same quarter last year. During the same quarter last year, the firm earned $7.20 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, research analysts anticipate that UnitedHealth Group will post 17.66 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date was Monday, March 9th. UnitedHealth Group’s payout ratio is currently 67.02%.

Analyst Ratings Changes

A number of brokerages have commented on UNH. Evercore upgraded UnitedHealth Group to a “strong-buy” rating in a research note on Tuesday, January 6th. Wells Fargo & Company reduced their price objective on UnitedHealth Group from $400.00 to $370.00 and set an “overweight” rating on the stock in a research note on Friday, January 30th. Jefferies Financial Group boosted their price objective on UnitedHealth Group from $340.00 to $373.00 and gave the stock a “buy” rating in a research note on Monday. Mizuho dropped their target price on UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating on the stock in a research report on Thursday, February 5th. Finally, Leerink Partners dropped their target price on UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating on the stock in a research report on Wednesday, January 28th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $364.79.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q1 beat and guidance raise: UnitedHealth reported Q1 results that topped revenue and EPS expectations and raised FY‑2026 adjusted EPS guidance (now > $18.25), signaling better control of medical costs and supporting the rally. Read More.
• Positive Sentiment: AI investment and Optum scale: Management plans ~$1.5B in AI spending and Optum Real is rapidly scaling (hundreds of millions of transactions now, billions by year‑end), which investors view as a path to durable cost savings and higher fee‑based revenue. Read More.
• Positive Sentiment: Analyst upgrade / price‑target lift: Jefferies raised its UNH price target to $373 and reiterated a buy stance, adding upside conviction to the stock after the earnings beat. Read More.
• Positive Sentiment: Operational moves for provider relations: UnitedHealthcare expanded initiatives to cut prior‑authorization burdens and speed rural payments, which can reduce friction with providers and support membership and utilization trends. Read More.
• Neutral Sentiment: Sector lift / peer momentum: Strong UNH results lifted sentiment across insurers (Centene, Molina, Clover), amplifying buying flows into the group but not changing UNH’s fundamentals directly. Read More.
• Negative Sentiment: Policy/program uncertainty: UnitedHealth flagged “challenges” with a Medicare pilot to cover obesity drugs, creating execution and reimbursement uncertainty that could pressure medical cost trends. Read More.
• Negative Sentiment: Legacy Medicare payment pressure: Earlier reporting noted potential multi‑billion dollar Medicare payment headwinds that remain a watch item for margins despite the Q1 beat. Read More.

Institutional Trading of UnitedHealth Group

Several institutional investors and hedge funds have recently bought and sold shares of the company. Price T Rowe Associates Inc. MD raised its stake in UnitedHealth Group by 3.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 18,829,054 shares of the healthcare conglomerate’s stock valued at $6,215,660,000 after buying an additional 680,077 shares in the last quarter. Morgan Stanley raised its stake in UnitedHealth Group by 3.6% during the fourth quarter. Morgan Stanley now owns 15,790,095 shares of the healthcare conglomerate’s stock valued at $5,212,469,000 after buying an additional 553,413 shares in the last quarter. Northern Trust Corp raised its stake in UnitedHealth Group by 1.6% during the third quarter. Northern Trust Corp now owns 9,109,692 shares of the healthcare conglomerate’s stock valued at $3,145,577,000 after buying an additional 144,109 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in UnitedHealth Group by 4.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 8,440,352 shares of the healthcare conglomerate’s stock valued at $2,786,248,000 after buying an additional 378,453 shares in the last quarter. Finally, Amundi raised its stake in UnitedHealth Group by 26.6% during the fourth quarter. Amundi now owns 7,356,057 shares of the healthcare conglomerate’s stock valued at $2,428,309,000 after buying an additional 1,544,066 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.